CLINICAL_TRIALS
research
· 2026-03-12
Clinical Trial Update: Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment [Phase 3]
Summary
Phase 3 trial assessing dalpiciclib plus endocrine therapy with or without metronomic capecitabine as first-line treatment for breast cancer; currently recruiti…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fujian Cancer Hospital | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING